127 related articles for article (PubMed ID: 528095)
1. In vitro and in vivo characteristics of some commercial phenobarbital tablets.
Sylvestri MF; Ueda CT
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):492-7. PubMed ID: 528095
[TBL] [Abstract][Full Text] [Related]
2. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
Gordon MS; Chowhan Z
Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
[TBL] [Abstract][Full Text] [Related]
3. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets.
Ammar HO; Khalil RM; Omar SM
Pharmazie; 1993 Dec; 48(12):932-5. PubMed ID: 8115438
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability of three commercial acetaminophen tablets.
Hekimoğlu S; Ayanoğlu-Dülger G; Hincal AA
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):93-6. PubMed ID: 3557735
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
Khan MK; Khan MF; Khan H; Mustafa G
Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
Ahmed IS; Aboul-Einien MH
Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
[TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets.
el-Sayed Y; Suleiman MS; Hasan M; Najib N; Muti H; Abdulhameed M
Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):487-91. PubMed ID: 3235214
[TBL] [Abstract][Full Text] [Related]
9. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.
Babalola CP; Oladimeji FA; Femi-Oyewo MN
Afr J Med Med Sci; 2001 Dec; 30(4):275-80. PubMed ID: 14510103
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability of two tablet formulations of acyclovir in healthy volunteers.
Al-Yamani MJ; Al-Khamis KI; El-Sayed YM; Bawazir SA; Al-Rashood KA; Gouda MW
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):222-6. PubMed ID: 9587049
[TBL] [Abstract][Full Text] [Related]
11. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
[TBL] [Abstract][Full Text] [Related]
13. Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation.
He Z; Zhong D; Chen X; Liu X; Tang X; Zhao L
Eur J Pharm Sci; 2004 Mar; 21(4):487-91. PubMed ID: 14998579
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets.
Tulain U; Ur-Rahman N
Pak J Pharm Sci; 2008 Apr; 21(2):131-8. PubMed ID: 18390443
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and pharmacokinetics of furosemide marketed in Thailand.
Kaojarern S; Poobrasert O; Utiswannakul A; Kositchaiwat U
J Med Assoc Thai; 1990 Apr; 73(4):191-7. PubMed ID: 2394955
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.
Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S
J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tablets.
Ogata H; Aoyagi N; Kaniwa K; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):175-83. PubMed ID: 6715086
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates.
Ogata H; Aoyagi N; Kaniwa N; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):240-5. PubMed ID: 6746147
[TBL] [Abstract][Full Text] [Related]
20. Comparative bioavailability of two tablet formulations of diclofenac sodium in normal subjects.
Hasan MM; Najib NM; Rawashdeh NM; Sallam EN; Shubair MS; Alawneh Y
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):178-83. PubMed ID: 2071269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
